JAK2 inhibitors: a breakthrough in oncology? Interviewee/Contributor Jürg Eckhardt Organisation Bellevue Asset Management Cancer (Oncology) Janus kinase 2 inhibitors - JAK2 inhibitors Read more about JAK2 inhibitors: a breakthrough in oncology?